Celcuity Inc. (NASDAQ:CELC) Short Interest Up 6.4% in January

Celcuity Inc. (NASDAQ:CELC) was the recipient of a significant increase in short interest during the month of January. As of January 31st, there was short interest totalling 3,330,000 shares, an increase of 6.4% from the January 15th total of 3,130,000 shares. Based on an average trading volume of 283,600 shares, the short-interest ratio is currently 11.7 days.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the company. HC Wainwright reiterated a “buy” rating and issued a $27.00 target price on shares of Celcuity in a research report on Friday, November 15th. Needham & Company LLC lifted their price objective on Celcuity from $23.00 to $29.00 and gave the stock a “buy” rating in a research note on Thursday, February 6th. Six research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Celcuity presently has an average rating of “Buy” and a consensus target price of $30.17.

Institutional Investors Weigh In On Celcuity

Hedge funds have recently added to or reduced their stakes in the business. BNP Paribas Financial Markets increased its holdings in Celcuity by 2,083.4% in the third quarter. BNP Paribas Financial Markets now owns 45,110 shares of the company’s stock worth $673,000 after purchasing an additional 43,044 shares in the last quarter. Geode Capital Management LLC lifted its holdings in shares of Celcuity by 27.6% in the 3rd quarter. Geode Capital Management LLC now owns 630,369 shares of the company’s stock worth $9,401,000 after purchasing an additional 136,518 shares in the last quarter. State Street Corp grew its position in Celcuity by 152.2% in the 3rd quarter. State Street Corp now owns 1,107,415 shares of the company’s stock valued at $16,512,000 after purchasing an additional 668,318 shares during the period. Braidwell LP increased its stake in Celcuity by 71.2% during the 3rd quarter. Braidwell LP now owns 884,306 shares of the company’s stock valued at $13,185,000 after purchasing an additional 367,663 shares in the last quarter. Finally, Barclays PLC raised its holdings in Celcuity by 567.6% during the third quarter. Barclays PLC now owns 53,605 shares of the company’s stock worth $800,000 after buying an additional 45,576 shares during the last quarter. 63.33% of the stock is currently owned by institutional investors.

Celcuity Trading Down 0.9 %

CELC stock traded down $0.12 during mid-day trading on Tuesday, reaching $12.76. The company’s stock had a trading volume of 230,522 shares, compared to its average volume of 229,775. The company has a market cap of $473.78 million, a price-to-earnings ratio of -4.89 and a beta of 0.73. The business’s 50 day moving average price is $12.26 and its 200 day moving average price is $14.10. The company has a current ratio of 10.35, a quick ratio of 10.36 and a debt-to-equity ratio of 0.65. Celcuity has a 12 month low of $10.35 and a 12 month high of $22.19.

About Celcuity

Celcuity Inc, a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment.